HC Wainwright & Co. Maintains Buy on SpyGlass Pharma, Raises Price Target to $43
Benzinga Newsdesk 3 hours ago
Analyst RatingsNewsPrice Target
HC Wainwright & Co. analyst Yi Chen maintains SpyGlass Pharma (NASDAQ:SGP) with a Buy and raises the price target from $37 to $43.
HC Wainwright & Co. analyst Yi Chen maintains SpyGlass Pharma (NASDAQ:SGP) with a Buy and raises the price target from $37 to $43.